Mabwell (Shanghai) Bioscience Co., Ltd. (SHA:688062)
China · Delayed Price · Currency is CNY 39.42
-0.59 (-1.47%)
Jan 22, 2026, 3:00 PM CST
SHA:688062 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
Net Income | -947.49 | -1,044 | -1,053 | -955.23 | -769.59 | -642.55 | Upgrade |
Depreciation & Amortization | 129.21 | 129.21 | 104.31 | 89.29 | 80.46 | 56.39 | Upgrade |
Other Amortization | 17.01 | 17.01 | 5.14 | 6.58 | 6.82 | 6.57 | Upgrade |
Loss (Gain) From Sale of Assets | - | - | 0 | -0.33 | -2.06 | 0.01 | Upgrade |
Asset Writedown & Restructuring Costs | 0.11 | 0.11 | 3.56 | 0.02 | - | 1.94 | Upgrade |
Loss (Gain) From Sale of Investments | 4.07 | 4.07 | 1.25 | -1.8 | -3.85 | -15.52 | Upgrade |
Provision & Write-off of Bad Debts | 0.03 | 0.03 | 0.03 | -0.01 | -0.03 | 1.7 | Upgrade |
Other Operating Activities | 525.18 | 56.42 | 16.76 | 9.07 | 2.48 | -0.6 | Upgrade |
Change in Accounts Receivable | -77.36 | -77.36 | -42.88 | 15.21 | -24.01 | -12.72 | Upgrade |
Change in Inventory | -57.91 | -57.91 | -86.18 | -40.88 | -7.73 | -9.94 | Upgrade |
Change in Accounts Payable | -36.24 | -36.24 | 149.89 | 6.57 | 109.33 | 20.39 | Upgrade |
Change in Other Net Operating Assets | 28.82 | 28.82 | 118.2 | 152.33 | 185.77 | 79.33 | Upgrade |
Operating Cash Flow | -391.25 | -956.44 | -782.73 | -719.17 | -422.4 | -514.99 | Upgrade |
Capital Expenditures | -234.88 | -330.07 | -499.91 | -544.96 | -217.51 | -130.62 | Upgrade |
Sale of Property, Plant & Equipment | - | - | 0 | 0.01 | - | - | Upgrade |
Cash Acquisitions | -18.69 | - | -24 | - | - | - | Upgrade |
Divestitures | - | - | - | - | - | -0.05 | Upgrade |
Investment in Securities | -36.98 | 35.53 | 11.72 | -60 | 225.41 | -239.25 | Upgrade |
Other Investing Activities | 1.12 | 2.99 | 2.57 | 2.15 | 4.94 | 12.7 | Upgrade |
Investing Cash Flow | -289.44 | -291.55 | -509.62 | -602.8 | 12.84 | -357.22 | Upgrade |
Short-Term Debt Issued | - | - | - | - | - | 64 | Upgrade |
Long-Term Debt Issued | - | 3,605 | 605.3 | 460.07 | 142.87 | 50.04 | Upgrade |
Total Debt Issued | 2,652 | 3,605 | 605.3 | 460.07 | 142.87 | 114.04 | Upgrade |
Short-Term Debt Repaid | - | - | - | - | - | -237.5 | Upgrade |
Long-Term Debt Repaid | - | -2,705 | -133.06 | -37.91 | -69.09 | - | Upgrade |
Total Debt Repaid | -2,385 | -2,705 | -133.06 | -37.91 | -69.09 | -237.5 | Upgrade |
Net Debt Issued (Repaid) | 266.25 | 900.38 | 472.23 | 422.17 | 73.78 | -123.46 | Upgrade |
Issuance of Common Stock | - | - | - | 3,323 | 125.95 | 1,280 | Upgrade |
Common Dividends Paid | -79.24 | -66.11 | -34.1 | -13.12 | -0.79 | - | Upgrade |
Other Financing Activities | 334.8 | -2.57 | 6.8 | -16.1 | - | -1.04 | Upgrade |
Financing Cash Flow | 521.81 | 831.7 | 444.94 | 3,716 | 198.94 | 1,155 | Upgrade |
Foreign Exchange Rate Adjustments | -0.13 | 0.23 | 1.4 | 2.26 | -1.01 | -1.72 | Upgrade |
Net Cash Flow | -159.01 | -416.07 | -846.01 | 2,396 | -211.63 | 281.25 | Upgrade |
Free Cash Flow | -626.14 | -1,287 | -1,283 | -1,264 | -639.91 | -645.61 | Upgrade |
Free Cash Flow Margin | -100.26% | -643.96% | -1003.35% | -4559.01% | -3943.69% | -12176.27% | Upgrade |
Free Cash Flow Per Share | -1.57 | -3.22 | -3.21 | -3.23 | -2.14 | -2.27 | Upgrade |
Cash Interest Paid | - | - | - | - | - | 1.04 | Upgrade |
Cash Income Tax Paid | 40.94 | 20.98 | -69.09 | -141.94 | 0.99 | 0.89 | Upgrade |
Levered Free Cash Flow | -409.42 | -1,063 | -824.71 | -925.61 | -354.48 | -608.18 | Upgrade |
Unlevered Free Cash Flow | -359.23 | -1,027 | -816.37 | -919.18 | -350.47 | -607.53 | Upgrade |
Change in Working Capital | -119.37 | -119.37 | 139.65 | 133.23 | 263.37 | 77.06 | Upgrade |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.